£10m Cash Boost For UK Regulator To Speed Up New Drug Approvals
Tax Relief Move ‘A Huge Boost’ For Biotech
Executive Summary
An injection of new money should provide something of a shot in the arm for the UK’s drugs regulator as it deals with post-Brexit realities.